Unfavorable Clinical Outcome

Preferred Label : Unfavorable Clinical Outcome;

NCIt definition : A detrimental result in response to clinical management.;

Details

Origin ID

C38328;

UMLS CUI

C1519790;

Peut être observé dans la(les) pathologie(s)
- Acute Basophilic Leukemia [NCIt concept]
- Acute Bilineal Leukemia [NCIt concept]
- Acute Biphenotypic Leukemia [NCIt concept]
- Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Acute Leukemia of Ambiguous Lineage with BCL11B Rearrangement [NCIt concept]
- Acute Leukemia of Ambiguous Lineage with Defining Genetic Abnormalities [NCIt concept]
- Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified [NCIt concept]
- Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2 [NCIt concept]
- Acute Monoblastic Leukemia [NCIt concept]
- Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Acute Monocytic Leukemia [NCIt concept]
- Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome [NCIt concept]
- Acute Myeloid Leukemia with FLT3/ITD Mutation [NCIt concept]
- Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Acute Myeloid Leukemia with Multilineage Dysplasia [NCIt concept]
- Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A [NCIt concept]
- Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A [NCIt concept]
- Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214 [NCIt concept]
- Acute Myeloid Leukemia without Maturation [NCIt concept]
- Acute Myeloid Leukemia, Myelodysplasia-Related [NCIt concept]
- Acute Undifferentiated Leukemia [NCIt concept]
- Adult Acute Basophilic Leukemia [NCIt concept]
- Adult Acute Monoblastic Leukemia [NCIt concept]
- Adult Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Adult Acute Monocytic Leukemia [NCIt concept]
- Adult Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Adult Acute Myeloid Leukemia without Maturation [NCIt concept]
- Adult Anaplastic (Malignant) Meningioma [NCIt concept]
- Adult Anaplastic Astrocytoma [NCIt concept]
- Adult Anaplastic Ependymoma [NCIt concept]
- Adult Anaplastic Oligodendroglioma [NCIt concept]
- Adult Atypical Meningioma [NCIt concept]
- Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- Adult Brain Glioblastoma [NCIt concept]
- Adult Brain Stem Gliosarcoma [NCIt concept]
- Adult Cholangiocarcinoma [NCIt concept]
- Adult Diffuse Hemispheric Glioma, H3 G34-Mutant [NCIt concept]
- Adult Diffuse Intrinsic Pontine Glioma [NCIt concept]
- Adult Diffuse Midline Glioma [NCIt concept]
- Adult Diffuse Midline Glioma, H3 K27-Altered [NCIt concept]
- Adult Giant Cell Glioblastoma [NCIt concept]
- Adult Glioblastoma [NCIt concept]
- Adult Gliosarcoma [NCIt concept]
- Adult Grade 2 Meningioma [NCIt concept]
- Adult Grade 3 Meningioma [NCIt concept]
- Adult Papillary Meningioma [NCIt concept]
- Adult Spinal Cord Glioblastoma [NCIt concept]
- Adult Supratentorial Ependymoma ZFTA Fusion-Positive [NCIt concept]
- Adult Unfavorable Prognosis Hodgkin Lymphoma [NCIt concept]
- Advanced Cholangiocarcinoma [NCIt concept]
- Advanced Distal Cholangiocarcinoma [NCIt concept]
- Advanced Glioblastoma [NCIt concept]
- Advanced HER2-Positive Breast Carcinoma [NCIt concept]
- Advanced Hilar Cholangiocarcinoma [NCIt concept]
- Advanced Intrahepatic Cholangiocarcinoma [NCIt concept]
- Advanced Microsatellite Stable Ovarian Carcinoma [NCIt concept]
- Advanced Ovarian Carcinoma [NCIt concept]
- Advanced Ovarian Carcinosarcoma [NCIt concept]
- Advanced Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Advanced Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Advanced Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Advanced Ovarian Serous Adenocarcinoma [NCIt concept]
- Advanced Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Advanced Platinum-Refractory Ovarian Carcinoma [NCIt concept]
- Advanced Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Advanced Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Advanced Triple-Negative Breast Carcinoma [NCIt concept]
- Advanced Unfavorable Hodgkin Lymphoma [NCIt concept]
- Advanced Unfavorable Non-Hodgkin Lymphoma [NCIt concept]
- Aleukemic Acute Lymphoblastic Leukemia Cutis [NCIt concept]
- Aleukemic Leukemia Cutis [NCIt concept]
- Aleukemic Monocytic Leukemia Cutis [NCIt concept]
- Alkylating Agent-Related Acute Myeloid Leukemia [NCIt concept]
- Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome [NCIt concept]
- Alkylating Agent-Related Myelodysplastic Syndrome [NCIt concept]
- Alpha Heavy Chain Disease [NCIt concept]
- Anaplastic (Malignant) Intracranial Meningioma [NCIt concept]
- Anaplastic (Malignant) Intraspinal Meningioma [NCIt concept]
- Anaplastic (Malignant) Meningioma [NCIt concept]
- Anaplastic Astrocytoma [NCIt concept]
- Anaplastic Astrocytoma, IDH-Wildtype [NCIt concept]
- Anaplastic Astrocytoma, Not Otherwise Specified [NCIt concept]
- Anaplastic Brain Stem Astrocytoma [NCIt concept]
- Anaplastic Brain Stem Glioma [NCIt concept]
- Anaplastic Diencephalic Astrocytoma [NCIt concept]
- Anaplastic Ependymoma [NCIt concept]
- Anaplastic Oligoastrocytoma [NCIt concept]
- Anaplastic Oligoastrocytoma, Not Otherwise Specified [NCIt concept]
- Anaplastic Oligodendroglioma [NCIt concept]
- Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted [NCIt concept]
- Anaplastic Oligodendroglioma, Not Otherwise Specified [NCIt concept]
- Anaplastic Pleomorphic Xanthoastrocytoma [NCIt concept]
- Astrocytoma, IDH-Mutant, Grade 3 [NCIt concept]
- Astrocytoma, IDH-Mutant, Grade 4 [NCIt concept]
- Atypical Meningioma [NCIt concept]
- B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3); KMT2A-AFF1 [NCIt concept]
- B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Lymphoid Only Involvement [NCIt concept]
- B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Multilineage Involvement [NCIt concept]
- B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged [NCIt concept]
- B-Cell Prolymphocytic Leukemia [NCIt concept]
- BRCA Hereditary Ovarian Carcinoma [NCIt concept]
- Basal-Like Breast Carcinoma [NCIt concept]
- Borderline Resectable Intrahepatic Cholangiocarcinoma [NCIt concept]
- Brain Glioblastoma [NCIt concept]
- Brain Stem Glioblastoma [NCIt concept]
- Brain Stem Intraparenchymal Clear Cell Meningioma [NCIt concept]
- Cerebellar Glioblastoma [NCIt concept]
- Cerebellar Papillary Meningioma [NCIt concept]
- Cerebral Glioblastoma [NCIt concept]
- Childhood Acute Basophilic Leukemia [NCIt concept]
- Childhood Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Childhood Acute Monoblastic Leukemia [NCIt concept]
- Childhood Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Childhood Acute Monocytic Leukemia [NCIt concept]
- Childhood Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Childhood Acute Myeloid Leukemia without Maturation [NCIt concept]
- Childhood Anaplastic Astrocytoma [NCIt concept]
- Childhood Anaplastic Ependymoma [NCIt concept]
- Childhood Anaplastic Oligoastrocytoma [NCIt concept]
- Childhood Anaplastic Oligodendroglioma [NCIt concept]
- Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- Childhood Brain Anaplastic Astrocytoma [NCIt concept]
- Childhood Brain Glioblastoma [NCIt concept]
- Childhood Brain Stem Gliosarcoma [NCIt concept]
- Childhood Cerebellar Anaplastic Astrocytoma [NCIt concept]
- Childhood Cerebral Anaplastic Astrocytoma [NCIt concept]
- Childhood Diffuse Hemispheric Glioma, H3 G34-Mutant [NCIt concept]
- Childhood Diffuse Intrinsic Pontine Glioma [NCIt concept]
- Childhood Diffuse Midline Glioma [NCIt concept]
- Childhood Diffuse Midline Glioma, H3 K27-Altered [NCIt concept]
- Childhood Giant Cell Glioblastoma [NCIt concept]
- Childhood Glioblastoma [NCIt concept]
- Childhood Gliomatosis Cerebri [NCIt concept]
- Childhood Gliosarcoma [NCIt concept]
- Childhood Grade 2 Meningioma [NCIt concept]
- Childhood Grade 3 Meningioma [NCIt concept]
- Childhood Malignant Glioma [NCIt concept]
- Childhood Ovarian Choriocarcinoma [NCIt concept]
- Childhood Ovarian Small Cell Carcinoma, Hypercalcemic Type [NCIt concept]
- Childhood Supratentorial Ependymoma ZFTA Fusion-Positive [NCIt concept]
- Childhood Unfavorable Prognosis Hodgkin Lymphoma [NCIt concept]
- Childhood WHO Grade 3 Glioma [NCIt concept]
- Childhood WHO Grade 4 Glioma [NCIt concept]
- Cholangiocarcinoma [NCIt concept]
- Cholangiolocellular Carcinoma [NCIt concept]
- Chordoid Meningioma [NCIt concept]
- Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene [NCIt concept]
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene [NCIt concept]
- Classical Glioblastoma [NCIt concept]
- Clear Cell Intrahepatic Cholangiocarcinoma [NCIt concept]
- Clear Cell Meningioma [NCIt concept]
- Cutaneous Chronic Lymphocytic Leukemia [NCIt concept]
- DS Stage IA Multiple Myeloma [NCIt concept]
- DS Stage IB Multiple Myeloma [NCIt concept]
- DS Stage II Multiple Myeloma [NCIt concept]
- DS Stage IIA Multiple Myeloma [NCIt concept]
- DS Stage IIB Multiple Myeloma [NCIt concept]
- DS Stage IIIA Multiple Myeloma [NCIt concept]
- DS Stage IIIB Multiple Myeloma [NCIt concept]
- Diencephalic Glioblastoma [NCIt concept]
- Diffuse Hemispheric Glioma, H3 G34-Mutant [NCIt concept]
- Diffuse Intrinsic Pontine Glioma [NCIt concept]
- Diffuse Midline Glioma [NCIt concept]
- Diffuse Midline Glioma with EZHIP Overexpression [NCIt concept]
- Diffuse Midline Glioma, EGFR-Mutant [NCIt concept]
- Diffuse Midline Glioma, H3 K27-Altered [NCIt concept]
- Diffuse Midline Glioma, H3 K27M-Mutant [NCIt concept]
- Diffuse Non-Pontine Midline Glioma [NCIt concept]
- Diffuse Pediatric-Type High Grade Glioma MYCN [NCIt concept]
- Diffuse Pediatric-Type High Grade Glioma RTK1 [NCIt concept]
- Diffuse Pediatric-Type High Grade Glioma RTK2 [NCIt concept]
- Diffuse Pediatric-Type High Grade Glioma, H3-Wildtype and IDH-Wildtype [NCIt concept]
- Distal Cholangiocarcinoma [NCIt concept]
- Early Stage Triple-Negative Breast Carcinoma [NCIt concept]
- Early Unfavorable Hodgkin Lymphoma [NCIt concept]
- Early Unfavorable Non-Hodgkin Lymphoma [NCIt concept]
- Epithelioid Glioblastoma [NCIt concept]
- Extrahepatic Cholangiocarcinoma [NCIt concept]
- FIGO Grade 1 Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- FIGO Grade 2 Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- FIGO Stage IC Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IC1 Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IC2 Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IC3 Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage II Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage III Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IIIA Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IIIA1 Ovarian Cancer [NCIt concept]
- FIGO Stage IIIA1(i) Ovarian Cancer [NCIt concept]
- FIGO Stage IIIA1(ii) Ovarian Cancer [NCIt concept]
- FIGO Stage IIIA2 Ovarian Cancer [NCIt concept]
- FIGO Stage IIIB Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IIIC Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IV Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IVA Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IVB Ovarian Cancer 2014 [NCIt concept]
- Frontal Lobe Anaplastic Astrocytoma [NCIt concept]
- Frontal Lobe Anaplastic Oligodendroglioma [NCIt concept]
- Giant Cell Glioblastoma [NCIt concept]
- Glioblastoma [NCIt concept]
- Glioblastoma by Gene Expression Profile [NCIt concept]
- Glioblastoma with Primitive Neuronal Component [NCIt concept]
- Glioblastoma, IDH-Wildtype [NCIt concept]
- Glioblastoma, Not Otherwise Specified [NCIt concept]
- Gliomatosis Cerebri [NCIt concept]
- Gliomatosis Cerebri Type I [NCIt concept]
- Gliomatosis Cerebri Type II [NCIt concept]
- Gliosarcoma [NCIt concept]
- Grade 2 Meningioma [NCIt concept]
- Grade 3 Meningioma [NCIt concept]
- Granular Cell Glioblastoma [NCIt concept]
- HER2-Positive Breast Carcinoma [NCIt concept]
- Heavy Chain Deposition Disease [NCIt concept]
- Hemispheric Anaplastic Astrocytoma [NCIt concept]
- Hereditary Ovarian Carcinoma [NCIt concept]
- High Grade Astrocytic Tumor [NCIt concept]
- High Grade Astrocytoma with Piloid Features [NCIt concept]
- Hilar Cholangiocarcinoma [NCIt concept]
- Hilar Cholangiocarcinoma by AJCC v7 Stage [NCIt concept]
- Hilar Cholangiocarcinoma by AJCC v8 Stage [NCIt concept]
- Hypodiploid B Acute Lymphoblastic Leukemia [NCIt concept]
- Hypodiploid B Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- Infant Acute Biphenotypic Leukemia [NCIt concept]
- Infant Acute Undifferentiated Leukemia [NCIt concept]
- Infant-Type Hemispheric Glioma [NCIt concept]
- Infant-Type Hemispheric Glioma, ALK-Altered [NCIt concept]
- Infant-Type Hemispheric Glioma, MET-Altered [NCIt concept]
- Infant-Type Hemispheric Glioma, NTRK-Altered [NCIt concept]
- Infant-Type Hemispheric Glioma, ROS1-Altered [NCIt concept]
- Infratentorial Glioblastoma [NCIt concept]
- Intrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma [NCIt concept]
- Intrahepatic Cholangiocarcinoma [NCIt concept]
- Intrahepatic Cholangiocarcinoma by AJCC v7 Stage [NCIt concept]
- Intrahepatic Cholangiocarcinoma by AJCC v8 Stage [NCIt concept]
- Large Duct Intrahepatic Cholangiocarcinoma [NCIt concept]
- Leukemia Cutis [NCIt concept]
- Light Chain Deposition Disease [NCIt concept]
- Light and Heavy Chain Deposition Disease [NCIt concept]
- Lipidized Glioblastoma [NCIt concept]
- Locally Advanced Cholangiocarcinoma [NCIt concept]
- Locally Advanced Distal Cholangiocarcinoma [NCIt concept]
- Locally Advanced Glioblastoma [NCIt concept]
- Locally Advanced Glioma [NCIt concept]
- Locally Advanced HER2-Positive Breast Carcinoma [NCIt concept]
- Locally Advanced Intrahepatic Cholangiocarcinoma [NCIt concept]
- Locally Advanced Ovarian Carcinoma [NCIt concept]
- Locally Advanced Ovarian Serous Adenocarcinoma [NCIt concept]
- Locally Advanced Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Locally Advanced Pituitary Neuroendocrine Tumor [NCIt concept]
- Locally Advanced Platinum-Refractory Ovarian Carcinoma [NCIt concept]
- Locally Advanced Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Locally Advanced Triple-Negative Breast Carcinoma [NCIt concept]
- Locally Advanced Unresectable Cholangiocarcinoma [NCIt concept]
- Locally Advanced Unresectable HER2-Positive Breast Carcinoma [NCIt concept]
- Locally Advanced Unresectable Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Triple-Negative Breast Carcinoma [NCIt concept]
- Locally Recurrent Ovarian Carcinoma [NCIt concept]
- Low-Hypodiploid B Acute Lymphoblastic Leukemia [NCIt concept]
- MGMT-Methylated Glioblastoma [NCIt concept]
- MGMT-Unmethylated Glioblastoma [NCIt concept]
- Malignant Brain Glioma [NCIt concept]
- Malignant Glioma [NCIt concept]
- Malignant Ovarian Brenner Tumor [NCIt concept]
- Malignant Ovarian Clear Cell Tumor [NCIt concept]
- Malignant Ovarian Endometrioid Tumor [NCIt concept]
- Malignant Ovarian Mucinous Tumor [NCIt concept]
- Malignant Ovarian Serous Tumor [NCIt concept]
- Medulloblastoma, Non-WNT/Non-SHH, Group 3 [NCIt concept]
- Meningeal Gliomatosis [NCIt concept]
- Mesenchymal Glioblastoma [NCIt concept]
- Metastatic Childhood Astrocytoma by Toronto Guidelines v2 [NCIt concept]
- Metastatic Cholangiocarcinoma [NCIt concept]
- Metastatic Corticotroph Pituitary Neuroendocrine Tumor [NCIt concept]
- Metastatic Distal Cholangiocarcinoma [NCIt concept]
- Metastatic Glioblastoma [NCIt concept]
- Metastatic Glioma [NCIt concept]
- Metastatic HER2-Positive Breast Carcinoma [NCIt concept]
- Metastatic Hilar Cholangiocarcinoma [NCIt concept]
- Metastatic Intrahepatic Cholangiocarcinoma [NCIt concept]
- Metastatic Lactotroph Pituitary Neuroendocrine Tumor [NCIt concept]
- Metastatic Low Grade Astrocytoma [NCIt concept]
- Metastatic Low Grade Glioma [NCIt concept]
- Metastatic Microsatellite Stable Ovarian Carcinoma [NCIt concept]
- Metastatic Ovarian Carcinoma [NCIt concept]
- Metastatic Ovarian Carcinosarcoma [NCIt concept]
- Metastatic Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Metastatic Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Metastatic Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Metastatic Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Metastatic Ovarian Serous Adenocarcinoma [NCIt concept]
- Metastatic Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type [NCIt concept]
- Metastatic Ovarian Undifferentiated Carcinoma [NCIt concept]
- Metastatic Pituitary Neuroendocrine Tumor [NCIt concept]
- Metastatic Platinum-Refractory Ovarian Carcinoma [NCIt concept]
- Metastatic Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Metastatic Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Metastatic Somatotroph Pituitary Neuroendocrine Tumor [NCIt concept]
- Metastatic Thyrotroph Pituitary Neuroendocrine Tumor [NCIt concept]
- Metastatic Triple-Negative Breast Carcinoma [NCIt concept]
- Metastatic Triple-Negative Breast Inflammatory Carcinoma [NCIt concept]
- Metastatic Unresectable Pituitary Neuroendocrine Tumor [NCIt concept]
- Microsatellite Stable Ovarian Carcinoma [NCIt concept]
- Mixed Phenotype Acute Leukemia [NCIt concept]
- Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion [NCIt concept]
- Mixed Phenotype Acute Leukemia with KMT2A Rearrangement [NCIt concept]
- Mixed Phenotype Acute Leukemia, B/Myeloid [NCIt concept]
- Mixed Phenotype Acute Leukemia, B/T [NCIt concept]
- Mixed Phenotype Acute Leukemia, B/T/Myeloid [NCIt concept]
- Mixed Phenotype Acute Leukemia, Rare Types [NCIt concept]
- Mixed Phenotype Acute Leukemia, T/Megakaryocytic [NCIt concept]
- Mixed Phenotype Acute Leukemia, T/Myeloid [NCIt concept]
- Mucin-Producing Intrahepatic Cholangiocarcinoma [NCIt concept]
- Multifocal Glioblastomas [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia with Mutated TP53 [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified [NCIt concept]
- Near-Haploid B Acute Lymphoblastic Leukemia [NCIt concept]
- Neural Glioblastoma [NCIt concept]
- Non-Gestational Ovarian Choriocarcinoma [NCIt concept]
- Oligometastatic Intrahepatic Cholangiocarcinoma [NCIt concept]
- Opisthorchis Viverrini-Related Cholangiocarcinoma [NCIt concept]
- Ovarian Adenocarcinoma [NCIt concept]
- Ovarian Cancer by AJCC v6 and v7 Stage [NCIt concept]
- Ovarian Cancer by AJCC v8 Stage [NCIt concept]
- Ovarian Cancer by FIGO Stage 2014 [NCIt concept]
- Ovarian Carcinoma [NCIt concept]
- Ovarian Carcinosarcoma [NCIt concept]
- Ovarian Choriocarcinoma [NCIt concept]
- Ovarian Clear Cell Adenocarcinofibroma [NCIt concept]
- Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Ovarian Clear Cell Cystadenocarcinoma [NCIt concept]
- Ovarian Cystadenocarcinoma [NCIt concept]
- Ovarian Dedifferentiated Carcinoma [NCIt concept]
- Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation [NCIt concept]
- Ovarian Gestational Choriocarcinoma [NCIt concept]
- Ovarian High Grade Endometrioid Adenocarcinoma [NCIt concept]
- Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Ovarian Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Ovarian Low Grade Endometrioid Adenocarcinoma [NCIt concept]
- Ovarian Low Grade Serous Adenocarcinoma [NCIt concept]
- Ovarian Mesonephric-Like Adenocarcinoma [NCIt concept]
- Ovarian Mixed Cell Adenocarcinoma [NCIt concept]
- Ovarian Mucinous Adenocarcinofibroma [NCIt concept]
- Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Ovarian Mucinous Cystadenocarcinoma [NCIt concept]
- Ovarian Neuroendocrine Carcinoma [NCIt concept]
- Ovarian Seromucinous Carcinoma [NCIt concept]
- Ovarian Serous Adenocarcinofibroma [NCIt concept]
- Ovarian Serous Adenocarcinoma [NCIt concept]
- Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Ovarian Serous Surface Papillary Adenocarcinoma [NCIt concept]
- Ovarian Signet Ring Cell Adenocarcinoma [NCIt concept]
- Ovarian Small Cell Carcinoma [NCIt concept]
- Ovarian Small Cell Carcinoma, Hypercalcemic Type [NCIt concept]
- Ovarian Small Cell Carcinoma, Pulmonary-Type [NCIt concept]
- Ovarian Squamous Cell Carcinoma [NCIt concept]
- Ovarian Transitional Cell Carcinoma [NCIt concept]
- Ovarian Undifferentiated Carcinoma [NCIt concept]
- Papillary Meningioma [NCIt concept]
- Parietal Lobe Anaplastic Astrocytoma [NCIt concept]
- Platinum-Refractory Ovarian Carcinoma [NCIt concept]
- Platinum-Refractory Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Platinum-Sensitive Ovarian Carcinoma [NCIt concept]
- Poor Prognosis Metastatic Gestational Trophoblastic Tumor [NCIt concept]
- Prolymphocytic Leukemia [NCIt concept]
- Proneural Glioblastoma [NCIt concept]
- Recurrent Acute Bilineal Leukemia [NCIt concept]
- Recurrent Acute Biphenotypic Leukemia [NCIt concept]
- Recurrent Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Recurrent Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Recurrent Acute Monocytic Leukemia [NCIt concept]
- Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia [NCIt concept]
- Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related [NCIt concept]
- Recurrent Acute Undifferentiated Leukemia [NCIt concept]
- Recurrent Anaplastic (Malignant) Meningioma [NCIt concept]
- Recurrent Anaplastic Astrocytoma [NCIt concept]
- Recurrent Anaplastic Astrocytoma, IDH-Wildtype [NCIt concept]
- Recurrent Anaplastic Ependymoma [NCIt concept]
- Recurrent Anaplastic Oligoastrocytoma [NCIt concept]
- Recurrent Anaplastic Oligodendroglioma [NCIt concept]
- Recurrent Anaplastic Pleomorphic Xanthoastrocytoma [NCIt concept]
- Recurrent Astrocytoma, IDH-Mutant, Grade 3 [NCIt concept]
- Recurrent Astrocytoma, IDH-Mutant, Grade 4 [NCIt concept]
- Recurrent Atypical Meningioma [NCIt concept]
- Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- Recurrent B-Cell Prolymphocytic Leukemia [NCIt concept]
- Recurrent BRCA Hereditary Ovarian Carcinoma [NCIt concept]
- Recurrent Brain Glioblastoma [NCIt concept]
- Recurrent Childhood Anaplastic Astrocytoma [NCIt concept]
- Recurrent Childhood Anaplastic Oligoastrocytoma [NCIt concept]
- Recurrent Childhood Anaplastic Oligodendroglioma [NCIt concept]
- Recurrent Childhood Diffuse Midline Glioma [NCIt concept]
- Recurrent Childhood Giant Cell Glioblastoma [NCIt concept]
- Recurrent Childhood Glioblastoma [NCIt concept]
- Recurrent Childhood Gliomatosis Cerebri [NCIt concept]
- Recurrent Childhood Gliosarcoma [NCIt concept]
- Recurrent Childhood Malignant Glioma [NCIt concept]
- Recurrent Cholangiocarcinoma [NCIt concept]
- Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant [NCIt concept]
- Recurrent Diffuse Intrinsic Pontine Glioma [NCIt concept]
- Recurrent Diffuse Midline Glioma [NCIt concept]
- Recurrent Diffuse Midline Glioma, H3 K27M-Mutant [NCIt concept]
- Recurrent Distal Cholangiocarcinoma [NCIt concept]
- Recurrent Giant Cell Glioblastoma [NCIt concept]
- Recurrent Glioblastoma [NCIt concept]
- Recurrent Glioblastoma, IDH-Wildtype [NCIt concept]
- Recurrent Gliomatosis Cerebri [NCIt concept]
- Recurrent Gliosarcoma [NCIt concept]
- Recurrent HER2-Positive Breast Carcinoma [NCIt concept]
- Recurrent Intrahepatic Cholangiocarcinoma [NCIt concept]
- Recurrent MGMT-Methylated Glioblastoma [NCIt concept]
- Recurrent Malignant Glioma [NCIt concept]
- Recurrent Malignant Ovarian Brenner Tumor [NCIt concept]
- Recurrent Mixed Phenotype Acute Leukemia [NCIt concept]
- Recurrent Multiple Myeloma [NCIt concept]
- Recurrent Myelodysplastic Syndrome/Acute Myeloid Leukemia [NCIt concept]
- Recurrent Ovarian Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Carcinoma [NCIt concept]
- Recurrent Ovarian Carcinosarcoma [NCIt concept]
- Recurrent Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Cystadenocarcinoma [NCIt concept]
- Recurrent Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Ovarian High Grade Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Low Grade Serous Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Seromucinous Carcinoma [NCIt concept]
- Recurrent Ovarian Serous Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Recurrent Ovarian Transitional Cell Carcinoma [NCIt concept]
- Recurrent Ovarian Undifferentiated Carcinoma [NCIt concept]
- Recurrent Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Recurrent Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Recurrent Platinum-Sensitive Ovarian Carcinoma [NCIt concept]
- Recurrent Small Cell Glioblastoma [NCIt concept]
- Recurrent Supratentorial Glioblastoma [NCIt concept]
- Recurrent T-Cell Prolymphocytic Leukemia [NCIt concept]
- Recurrent Triple-Negative Breast Carcinoma [NCIt concept]
- Recurrent WHO Grade 3 Glioma [NCIt concept]
- Recurrent WHO Grade 4 Glioma [NCIt concept]
- Refractory Acute Bilineal Leukemia [NCIt concept]
- Refractory Acute Biphenotypic Leukemia [NCIt concept]
- Refractory Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Refractory Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Refractory Acute Undifferentiated Leukemia [NCIt concept]
- Refractory Anaplastic Astrocytoma [NCIt concept]
- Refractory Anaplastic Ependymoma [NCIt concept]
- Refractory Anaplastic Oligodendroglioma [NCIt concept]
- Refractory Anaplastic Pleomorphic Xanthoastrocytoma [NCIt concept]
- Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- Refractory B-Cell Prolymphocytic Leukemia [NCIt concept]
- Refractory Cholangiocarcinoma [NCIt concept]
- Refractory Diffuse Intrinsic Pontine Glioma [NCIt concept]
- Refractory Distal Cholangiocarcinoma [NCIt concept]
- Refractory Giant Cell Glioblastoma [NCIt concept]
- Refractory Glioblastoma [NCIt concept]
- Refractory Gliosarcoma [NCIt concept]
- Refractory HER2-Positive Breast Carcinoma [NCIt concept]
- Refractory Intrahepatic Cholangiocarcinoma [NCIt concept]
- Refractory Malignant Glioma [NCIt concept]
- Refractory Malignant Ovarian Brenner Tumor [NCIt concept]
- Refractory Mixed Phenotype Acute Leukemia [NCIt concept]
- Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia [NCIt concept]
- Refractory Ovarian Adenocarcinoma [NCIt concept]
- Refractory Ovarian Carcinoma [NCIt concept]
- Refractory Ovarian Carcinosarcoma [NCIt concept]
- Refractory Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Refractory Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Refractory Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Refractory Ovarian Low Grade Serous Adenocarcinoma [NCIt concept]
- Refractory Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Refractory Ovarian Seromucinous Carcinoma [NCIt concept]
- Refractory Ovarian Serous Adenocarcinoma [NCIt concept]
- Refractory Ovarian Squamous Cell Carcinoma [NCIt concept]
- Refractory Ovarian Transitional Cell Carcinoma [NCIt concept]
- Refractory Ovarian Undifferentiated Carcinoma [NCIt concept]
- Refractory Small Cell Glioblastoma [NCIt concept]
- Refractory T-Cell Prolymphocytic Leukemia [NCIt concept]
- Refractory Triple-Negative Breast Carcinoma [NCIt concept]
- Refractory WHO Grade 3 Glioma [NCIt concept]
- Refractory WHO Grade 4 Glioma [NCIt concept]
- Resectable Anaplastic Astrocytoma [NCIt concept]
- Resectable Cholangiocarcinoma [NCIt concept]
- Resectable Glioblastoma [NCIt concept]
- Resectable Intrahepatic Cholangiocarcinoma [NCIt concept]
- Resectable Malignant Glioma [NCIt concept]
- Resectable Ovarian Carcinoma [NCIt concept]
- Resectable Triple-Negative Breast Carcinoma [NCIt concept]
- Rhabdoid Meningioma [NCIt concept]
- Sarcomatoid Intrahepatic Cholangiocarcinoma [NCIt concept]
- Secondary Glioblastoma [NCIt concept]
- Secondary Supratentorial Anaplastic Astrocytoma [NCIt concept]
- Signet Ring Cell Intrahepatic Cholangiocarcinoma [NCIt concept]
- Small Cell Glioblastoma [NCIt concept]
- Small Duct Intrahepatic Cholangiocarcinoma [NCIt concept]
- Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene [NCIt concept]
- Spinal Multifocal Clear Cell Meningioma [NCIt concept]
- Splenic Manifestation of B-Cell Prolymphocytic Leukemia [NCIt concept]
- Splenic Manifestation of Prolymphocytic Leukemia [NCIt concept]
- Splenic Manifestation of T-Cell Prolymphocytic Leukemia [NCIt concept]
- Stage 0 Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage 0 Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage I Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage I Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage I Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage I Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage I Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Ovarian Cancer AJCC v8 [NCIt concept]
- Stage I Ovarian Choriocarcinoma [NCIt concept]
- Stage IA Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IA Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IA Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IB Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IB Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IB Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IC Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IC Ovarian Cancer AJCC v8 [NCIt concept]
- Stage II Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage II Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage II Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage II Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage II Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Ovarian Cancer AJCC v8 [NCIt concept]
- Stage II Ovarian Choriocarcinoma [NCIt concept]
- Stage IIA Ovarian Cancer AJCC V6 and v7 [NCIt concept]
- Stage IIA Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIB Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIB Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIC Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage III Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage III Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage III Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Ovarian Cancer AJCC v8 [NCIt concept]
- Stage III Ovarian Choriocarcinoma [NCIt concept]
- Stage IIIA Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IIIA Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IIIA Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIA Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIIA1 Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIIA2 Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIIB Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IIIB Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IIIB Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIB Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIIC Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IIIC Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIC Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IV Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IV Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IV Ovarian Choriocarcinoma [NCIt concept]
- Stage IVA Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IVA Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IVA Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IVB Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IVB Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IVB Ovarian Cancer AJCC v8 [NCIt concept]
- Supratentorial Ependymoma ZFTA Fusion-Positive [NCIt concept]
- Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive [NCIt concept]
- Supratentorial Glioblastoma [NCIt concept]
- Supratentorial Gliosarcoma [NCIt concept]
- T-Cell Prolymphocytic Leukemia [NCIt concept]
- T-Cell Prolymphocytic Leukemia Involving the Skin [NCIt concept]
- T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant [NCIt concept]
- T-Cell Prolymphocytic Leukemia, Small Cell Variant [NCIt concept]
- Temporal Lobe Anaplastic Astrocytoma [NCIt concept]
- Triple-Class Refractory Multiple Myeloma [NCIt concept]
- Triple-Negative Breast Carcinoma [NCIt concept]
- Unfavorable Hodgkin Lymphoma [NCIt concept]
- Unfavorable Non-Hodgkin Lymphoma [NCIt concept]
- Unresectable Anaplastic Astrocytoma [NCIt concept]
- Unresectable Cholangiocarcinoma [NCIt concept]
- Unresectable Diffuse Hemispheric Glioma, H3 G34-Mutant [NCIt concept]
- Unresectable Diffuse Midline Glioma [NCIt concept]
- Unresectable Diffuse Midline Glioma, H3 K27M-Mutant [NCIt concept]
- Unresectable Distal Cholangiocarcinoma [NCIt concept]
- Unresectable Glioblastoma [NCIt concept]
- Unresectable HER2-Positive Breast Carcinoma [NCIt concept]
- Unresectable Hilar Cholangiocarcinoma [NCIt concept]
- Unresectable Intrahepatic Cholangiocarcinoma [NCIt concept]
- Unresectable Malignant Glioma [NCIt concept]
- Unresectable Ovarian Carcinoma [NCIt concept]
- Unresectable Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Unresectable Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Unresectable Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Unresectable Ovarian Serous Adenocarcinoma [NCIt concept]
- Unresectable Ovarian Undifferentiated Carcinoma [NCIt concept]
- Unresectable Platinum-Refractory Ovarian Carcinoma [NCIt concept]
- Unresectable Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Unresectable Triple-Negative Breast Carcinoma [NCIt concept]
- WHO Grade 3 Glioma [NCIt concept]
- WHO Grade 4 Glioma [NCIt concept]
Semantic type(s)
- Finding [UMLS semantic type]
is_finding_of_disease
- Aggressive Variant Prostate Carcinoma [NCIt concept]
- B Acute Lymphoblastic Leukemia with HLF Rearrangement [NCIt concept]
- B Acute Lymphoblastic Leukemia with MEF2D Rearrangement [NCIt concept]
- B Acute Lymphoblastic Leukemia with MYC Rearrangement [NCIt concept]
- B Acute Lymphoblastic Leukemia with TCF3-HLF Rearrangement [NCIt concept]
- B Acute Lymphoblastic Leukemia with TCF4-HLF Rearrangement [NCIt concept]
- B Acute Lymphoblastic Leukemia, BCR-ABL1-Like [NCIt concept]
- B Acute Lymphoblastic Leukemia, BCR-ABL1-Like [NCIt concept]
- B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL Class Rearranged [NCIt concept]
- B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL1 Rearranged [NCIt concept]
- B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, JAK-STAT Activated [NCIt concept]
- B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma with MYC Rearrangement [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like [NCIt concept]
- Hepatocellular Macrotrabecular Massive Carcinoma [NCIt concept]
- Intermediate Atypical Prostate Carcinoma [NCIt concept]
- Peripheral T-Cell Lymphoma-GATA3 [NCIt concept]
- Recurrent B Acute Lymphoblastic Leukemia, BCR-ABL1-Like [NCIt concept]
- Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like [NCIt concept]
- Uveal Class 2 Melanoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients